Abstract:Objectives: Acute coronary syndrome (ACS) is the major cause of mortality worldwide and caused mainly by atherosclerosis of coronary arteries. Apolipoprotein B100 (ApoB100) is a major component of low-density lipoprotein (LDL) and its oxidation can trigger inflammation in vascular endothelial cells leading to atherosclerosis. The association between antibodies to ApoB100-derived antigens and atherosclerotic diseases has been studied in recent years, but the findings appear to be controversial. The present study developed an ELISA in-house with ApoB100-derived peptide antigens to circulating anti-ApoB100 IgG antibodies in patients with ACS. Methods: Fifteen ApoB100-derived peptide antigens (Ag1–Ag15) were designed to develop an in-house ELISA for the detection of circulating anti-ApoB100 IgG levels in 350 patients with ACS and 201 control subjects amongst a Chinese population. Binary logistic regression was applied to examine the differences in anti-ApoB IgG levels between the patient group and the control group with adjustment for a number of confounding factors; the correlation between anti-ApoB100 IgG levels and clinical characteristics was also tested. Results: Patients with ACS had significantly higher levels of plasma IgG for Ag1 (adjusted P<0.001) and Ag10 antigens (adjusted P<0.001). There was no significant increase in the levels of IgG to the other 13 antigens in these ACS patients. In the control group, anti-Ag10 IgG levels were positively correlated with age, high-density lipoprotein (HDL), and ApoA levels (P≤0.001 for all) and negatively correlated with blood triglyceride (TG) (P=0.008); in the patient group, anti-Ag10 IgG levels were positively correlated with LDL (P=0.003), and negatively correlated with ApoA (P=0.048) and systolic blood pressure (SBP) (P=0.036). The area under ROC (receiver operator characteristic) curve (AUC) was 0.612 (95% confidence interval (CI): 0.560–0.664; P<0.001) in anti-Ag1 IgG assay and 0.621 (95% CI: 0.569–0.672; P<0.001) in anti-Ag10 IgG assay. Conclusion: Circulating IgG for ApoB100-derived peptide antigens may be a useful biomarker of ACS, although anti-ApoB IgG levels were not associated with the coronary artery plaque burden characterized by the coronary Gensini score.

[Increased Serum Apolipoprotein A5 in Patients with Acute Coronary Syndrome].

Elevated Plasma Apolipoprotein AV in Acute Coronary Syndrome is Positively Correlated with Triglyceride and C-reactive Protein.

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Association of plasma apolipoprotein AV with lipid profiles in patients with acute coronary syndrome.

The relationship between serum apolipoprotein A5 and coronary heart disease

Study on the Relationship between Serum Resistin and Acute Coronary Syndrome and Stable Angina Pectoris

Plasma Apolipoprotein O Level Increased in the Patients with Acute Coronary Syndrome

Relationship Between Autoantibodies Against Oxidized Low-Density Lipoprotein and High-Sensitivity C-reactive Protein in Patients with Coronary Artery Disease

Abstract: S5-17 APOLIPOPROTEIN AV IS A METABOLIC BIOMARKER LINKING INSULIN RESISTANCE WITH HYPERTRIGLYCERIDEMIA

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

Decreased Plasma Apolipoprotein A-Iv Levels in Patients with Acute Coronary Syndrome

Value of serum lipoprotein(a) measurement in patients with acute coronary syndrome

Elevated Levels of Oxidized Low-Density Lipoprotein Correlate Positively with C-Reactive Protein in Patients with Acute Coronary Syndrome

Inflammatory Factors in the Serum of Patients with Acute Coronary Syndrome:Changes and Their Implications

Associations Between Circulating IgG Antibodies to Apolipoprotein B100-derived Peptide Antigens and Acute Coronary Syndrome in a Chinese Han Population

Association of Apolipoprotein A1, High Density Lipoprotein Cholesterol, and Their Ratio with Inflammatory Marker in Chinese Adults with Coronary Artery Disease

Serum acute phase reactants sCRP, SAA, IL-6 in acute coronary syndrome and its clinical significance

Study of the Plasma Inflammation Marker and Blood Lipid in Acute Coronary Syndrome

Association of Human Serum Apolipoprotein A5 with Lipid Profiles Affected by Gender.

Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile.